Aktualności
EMEA: List of questions & answers (Q&A) received during the HMPC assessors training on quality issues emerging for herbal medicinal products
30.01.2009
EMEA:
List of questions & answers (Q&A) received during the Committee on Herbal Medicinal products (HMPC) assessors training on quality issues emerging for herbal medicinal products (held ...
List of questions & answers (Q&A) received during the Committee on Herbal Medicinal products (HMPC) assessors training on quality issues emerging for herbal medicinal products (held ...
EMEA: Draft EudraVigilance access policy for medicines for Veterinary use
30.01.2009
EMEA:
Draft EudraVigilance access policy for medicines for Veterinary use. This document should serve as a starting point for the elaboration of EudraVigilance access policies and the ...
Draft EudraVigilance access policy for medicines for Veterinary use. This document should serve as a starting point for the elaboration of EudraVigilance access policies and the ...
FDA: Guidance for Industry - Labeling OTC Human Drug Products – Questions and Answers
30.01.2009
FDA:
Guidance for industry - Labeling OTC Human Drug Products – Questions and Answers. This guidance is intended to assist manufacturers, packers, and distributors of over-the-counter ...
Guidance for industry - Labeling OTC Human Drug Products – Questions and Answers. This guidance is intended to assist manufacturers, packers, and distributors of over-the-counter ...
FDA: Comprehensive List of Guidance Documents
30.01.2009
FDA:
Center For Drug Evaluation and Research - Comprehensive List of Guidance Documents ...
Center For Drug Evaluation and Research - Comprehensive List of Guidance Documents ...
FDA: Guidance for Industry - Annex 2 Test for Extractable Volume of Parenteral Preparations General Chapter
30.01.2009
FDA:
Guidance for Industry - Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions. Annex 2 Test for Extractable Volume of Parenteral Preparations General ...
Guidance for Industry - Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions. Annex 2 Test for Extractable Volume of Parenteral Preparations General ...
FDA: Guidance for Industry - Annex 3 Test for Particulate Contamination: Subvisible Particles General Chapter
30.01.2009
FDA:
Guidance for Industry - Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions. Annex 3 Test for Particulate Contamination: Subvisible Particles General ...
Guidance for Industry - Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions. Annex 3 Test for Particulate Contamination: Subvisible Particles General ...
FDA: Guidance for Industry - Standards for Securing the Drug Supply Chain - Standardized Numerical Identification for Prescription Drug Packages (draft)
30.01.2009
FDA:
Guidance for Industry - Standards for Securing the Drug Supply Chain - Standardized Numerical Identification for Prescription Drug Packages (draft). In this guidance, FDA is ...
Guidance for Industry - Standards for Securing the Drug Supply Chain - Standardized Numerical Identification for Prescription Drug Packages (draft). In this guidance, FDA is ...
MHRA: Guidance on writing patient information leaflets
MHRA has developed specific guidance on writing patient information leaflets (PILs). ...
